Company: BNBX
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001104659-25-002521
Chunk: 29

Company: BNB PLUS CORP.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 29
---
”, “will”,
“expect”, “plan”, “anticipate”, “estimate”, “potential”, “position”,
“predicts”, “strategy”, “guidance”, “intend”, “budget”, “seek”,
“project” or “continue”, or the negative thereof or other comparable terminology regarding beliefs, plans, expectations
or intentions regarding the future. You should read statements that contain these words carefully because they:

| · | discuss our future expectations; |

| · | contain projections of                                              
 our future results of operations or of our financial condition; and |

| · | state other “forward-looking” 
 information.                  |

We believe it is important to communicate our
expectations. However, forward-looking statements are based on our current expectations, assumptions, estimates and projections about
our business and our industry and are subject to known and unknown risks, uncertainties and other factors. Accordingly, our actual results
and the timing of certain events may differ materially from those expressed or implied in such forward-looking statements due to a variety
of factors and risks, including, but not limited to, those set forth under “Risk Factors” in this prospectus, and the following
factors and risks:

| · | our expectations of future                                     
 revenues, expenditures, capital or other funding requirements; |

| · | the adequacy of our cash                                               
 and working capital to fund present and planned operations and growth; |

| · | the substantial doubt relating                 
 to our ability to continue as a going concern; |

| · | our need for additional                                                                                                                   
 financing which may in turn require the issuance of additional shares of Common Stock, preferred stock or other debt or equity securities 
 (including convertible securities) which would dilute the ownership held by stockholders;                                                 |

| · | our business strategy and                                                                                                              
 the timing of our expansion plans, including the development of new production facilities for our Therapeutic DNA Production Services; |

| · | demand for Therapeutic   
 DNA Production Services; |

| · | demand for DNA Tagging 
 Services;              |

| · | demand for MDx Testing 
 Services;              |

| · | our expectations concerning                                                                                
 existing or potential development and license agreements for third-party collaborations or joint ventures; |

<div align='center'>11</div>

| · | regulatory approval and                                                                                              
 compliance for our Therapeutic DNA Production Services, upon which our business strategy is substantially dependent; |

| · | the effect of governmental 
 regulations generally;     |

| · | our expectations of